With all the information you provided, is why I think the Covid-19 ART market is a minefield.
Seems to me that different companies are selectively reporting results/numbers, making it look better 'on paper', yet hides some of its defects behind numbers.
IMO, now that there are so many tests out on the market, TGA, CE, FDA should now reinforce companies to fill out a standardise spec sheet, so we can see the real numbers and compare properly. In a way, which is why TGA has hired the Doherty Institute to evaluate each and every EUA approved Covid-19 test now.
- Forums
- ASX - By Stock
- ADO
- Ann: AnteoTech COVID-19 Antigen Rapid Test Clinical Study Result
Ann: AnteoTech COVID-19 Antigen Rapid Test Clinical Study Result, page-99
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.002(9.09%) |
Mkt cap ! $59.24M |
Open | High | Low | Value | Volume |
2.2¢ | 2.4¢ | 2.2¢ | $54.26K | 2.389M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 197573 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 124808 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 197573 | 0.023 |
3 | 340301 | 0.022 |
8 | 1458170 | 0.021 |
12 | 1946809 | 0.020 |
8 | 1129867 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 124808 | 2 |
0.025 | 240865 | 5 |
0.028 | 190000 | 1 |
0.029 | 34000 | 3 |
0.030 | 350000 | 1 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |